Akoya Biosciences

AKYA48

Penny Stock

$2.82arrow_drop_up1.80%$0.05

Penny Stock

AKYA48

$2.82

arrow_drop_up1.80%$0.05

Penny Stock

Performance History

Key Stats
Open	$2.77
Prev. Close	$2.77
EPS	-1.17
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-
Market Cap	$137.11M
PE Ratio	-

	LOW	HIGH
Day Range	2.77	2.85
52 Week Range	1.88	6.31

Ratios







EPS	-1.17

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About Akoya Biosciences (AKYA)

Akoya Biosciences, Inc. (AKYA) is a leading provider of spatial biology solutions, enabling researchers to understand the complex interactions and relationships between cells in tissues. The company's innovative technology, the CODEX platform, allows for highly multiplexed imaging of cells and proteins in the context of intact tissue samples. This powerful tool provides researchers with a comprehensive view of the spatial organization and functional characteristics of cells, enabling a deeper understanding of disease mechanisms and the development of targeted therapies.

One of the key advantages of the CODEX platform is its ability to simultaneously image a large number of biomarkers, allowing for high-throughput analysis and improved data quality. This is particularly important in the field of immuno-oncology, where the tumor microenvironment plays a critical role in cancer progression and response to therapy. By providing a detailed spatial map of immune cells and their interactions with tumor cells, the CODEX platform can help identify novel biomarkers and inform the development of immunotherapies.

Websitecall_made

Sector: Healthcare
Industry: Medical Instruments & Supplies
CEO: Mr. Brian McKelligon
Headquarters: Marlborough
Employees: 369
Exchange: NASDAQ

Keep an eye on Akoya Biosciences

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is Akoya Biosciences's (AKYA) price per share?

The current price per share for Akoya Biosciences (AKYA) is $2.82. The stock has seen a price change of $0.05 recently, indicating a 1.81% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for Akoya Biosciences (AKYA)?

For Akoya Biosciences (AKYA), the 52-week high is $6.31, which is 123.76% from the current price. The 52-week low is $1.88, the current price is 50% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is Akoya Biosciences (AKYA) a growth stock?

Akoya Biosciences (AKYA) has shown an average price growth of 0.41% over the past three years. It has received a score of 10 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Akoya Biosciences as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is Akoya Biosciences (AKYA) stock price performance year to date (YTD)?

As of the latest data, Akoya Biosciences (AKYA) has a year-to-date price change of -41%. Over the past month, the stock has experienced a price change of 9.3%. Over the last three months, the change has been 17.01%. Over the past six months, the figure is -42.68%.

help

Is Akoya Biosciences (AKYA) a profitable company?

Akoya Biosciences (AKYA) has a net income of -$63.32M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 49.92% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -47.47% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $96.63M, with a revenue growth rate of 29.09%, providing insight into the company's sales performance and growth. The gross profit is $48.24M. Operating income is noted at -$56.03M. Furthermore, the EBITDA is -$39.49M.

help

What is the market capitalization of Akoya Biosciences (AKYA)?

Akoya Biosciences (AKYA) has a market capitalization of $137.11M. The average daily trading volume is 173.54K, indicating the stock's liquidity and investor engagement.